Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.

Authors: Klocke, Jan; Ulu, Arzu; Wu, Kaiyin; Rudolph, Birgit; Dragun, Duska; Gollasch, Maik; Schunck, Wolf-Hagen; Hammock, Bruce D; Riemekasten, Gabriela; Enghard, Philipp

Published In Sci Rep, (2019 Jun 20)

Abstract: Epoxy-fatty-acids (EpFAs), cytochrome P450 dependent arachidonic acid derivatives, have been suggested to have anti-inflammatory properties, though their effects on autoimmune diseases like systemic lupus erythematosus (SLE) have yet to be investigated. We assessed the influence of EpFAs and their metabolites in lupus prone NZB/W F1 mice by pharmacological inhibition of soluble epoxide hydrolase (sEH, EPHX2). The sEH inhibitor 1770 was administered to lupus prone NZB/W F1 mice in a prophylactic and a therapeutic setting. Prophylactic inhibition of sEH significantly improved survival and reduced proteinuria. By contrast, sEH inhibitor-treated nephritic mice had no survival benefit; however, histological changes were reduced when compared to controls. In humans, urinary EpFA levels were significantly different in 47 SLE patients when compared to 10 healthy controls. Gene expression of EPHX2 was significantly reduced in the kidneys of both NZB/W F1 mice and lupus nephritis (LN) patients. Correlation of EpFAs with SLE disease activity and reduced renal EPHX gene expression in LN suggest roles for these components in human disease.

PubMed ID: 31222024 Exiting the NIEHS site

MeSH Terms: Adult; Aged; Animals; Biomarkers; Biopsy; Case-Control Studies; Disease Models, Animal; Disease Progression; Enzyme Activation/drug effects; Enzyme Inhibitors/administration & dosage; Enzyme Inhibitors/pharmacology*; Epoxide Hydrolases/antagonists & inhibitors*; Female; Humans; Immunohistochemistry; Lipids; Lupus Nephritis/etiology; Lupus Nephritis/metabolism*; Lupus Nephritis/pathology*; Lupus Nephritis/prevention & control; Male; Mice; Mice, Inbred NZB; Middle Aged; Premedication*; Prognosis; Young Adult

Back
to Top